1. Home
  2. MFIC vs ACHV Comparison

MFIC vs ACHV Comparison

Compare MFIC & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MidCap Financial Investment Corporation

MFIC

MidCap Financial Investment Corporation

HOLD

Current Price

$9.05

Market Cap

744.6M

Sector

Finance

ML Signal

HOLD

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

HOLD

Current Price

$8.00

Market Cap

726.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MFIC
ACHV
Founded
2004
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
744.6M
726.5M
IPO Year
2004
2018

Fundamental Metrics

Financial Performance
Metric
MFIC
ACHV
Price
$9.05
$8.00
Analyst Decision
Hold
Strong Buy
Analyst Count
7
3
Target Price
$11.25
$14.67
AVG Volume (30 Days)
453.9K
1.4M
Earning Date
05-06-2026
05-11-2026
Dividend Yield
10.84%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.97
$2.62
52 Week High
$12.50
$8.64

Technical Indicators

Market Signals
Indicator
MFIC
ACHV
Relative Strength Index (RSI) 35.00 56.47
Support Level N/A $4.11
Resistance Level $9.95 $8.63
Average True Range (ATR) 0.17 0.38
MACD -0.03 -0.08
Stochastic Oscillator 6.67 56.75

Price Performance

Historical Comparison
MFIC
ACHV

About MFIC MidCap Financial Investment Corporation

MidCap Financial Investment Corp is an externally managed, publicly traded, closed-end, diversified management investment company. The investment objective of the company is to generate current income and, to a lesser extent, long-term capital appreciation. It predominantly invests in directly originated and privately negotiated first lien senior secured loans to privately held U.S. middle-market companies, and in other types of securities including, first lien unitranche, second lien senior secured, unsecured, subordinated, and mezzanine loans, and equities in both private and public middle market companies.

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

Share on Social Networks: